Osaka Organic Chemical Industry Ltd.TSE: 4187

Consolidated Financial Results for the Three Months Ended February 28, 2026(April 10, 2026 307KB)

· Issued by Osaka Organic Chemical Industry Ltd.

Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.

April 10, 2026

Consolidated Financial Results for the Three Months Ended February 28, 2026 (Under Japanese GAAP)

Company name:

OSAKA ORGANIC CHEMICAL INDUSTRY LTD.

Listing:

Tokyo Stock Exchange

Securities code:

4187

URL:

https://www.ooc.co.jp/

Representative:

Masayuki Ando

Representative Director and CEO

Inquiries:

Soichi Honda

Director, Corporate Officer, General Manager of Administration Division

Telephone:

+81-6-6264-5071

Scheduled date to commence dividend payments:

-

Preparation of supplementary material on financial results:

Yes

Holding of financial results briefing:

None

(Yen amounts are rounded down to millions, unless otherwise noted.)

  1. Consolidated financial results for the three months ended February 28, 2026 (from December 1, 2025 to February 28, 2026)
    1. Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)

      Net sales

      Operating profit

      Ordinary profit

      Profit attributable to owners of parent

      Three months ended

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      February 28, 2026

      9,072

      6.5

      1,832

      34.2

      1,904

      28.6

      1,285

      24.2

      February 28, 2025

      8,516

      20.5

      1,365

      135.2

      1,480

      131.3

      1,035

      71.6

      Note: Comprehensive income

      For the three months ended February 28, 2026:

      ¥

      3,114 million [

      272.9%]

      For the three months ended February 28, 2025:

      ¥

      835 million [

      (28.3) %]

      Basic earnings per share

      Diluted earnings per share

      Three months ended

      Yen

      Yen

      February 28, 2026

      63.22

      -

      February 28, 2025

      49.96

      -

    2. Consolidated financial position

    Total assets

    Net assets

    Equity-to-asset ratio

    As of

    Millions of yen

    Millions of yen

    %

    February 28, 2026

    65,452

    52,916

    79.4

    November 30, 2025

    63,713

    50,536

    78.0

    Reference: Equity

    As of February 28, 2026:

    ¥

    51,946 million

    As of November 30, 2025:

    ¥

    49,700 million

  2. Cash dividends

    Annual dividends per share

    First quarter-end

    Second quarter-end

    Third quarter-end

    Fiscal year-end

    Total

    Yen

    Yen

    Yen

    Yen

    Yen

    Fiscal year ended

    -

    35.00

    -

    40.00

    75.00

    November 30, 2025

    Fiscal year ending

    -

    November 30, 2026

    Fiscal year ending November 30, 2026

    (Forecast)

    40.00

    -

    40.00

    80.00

    Note: Revisions to the forecast of cash dividends most recently announced: None

    Note: Breakdown of the first quarter dividend for the fiscal year ending November 30, 2026 : Commemorative dividend - yen

    Special dividend - yen

  3. Consolidated financial result forecasts for the fiscal year ending November 30, 2026 (from December 1, 2025 to November 30, 2026)

(Percentages indicate year-on-year changes.)

Net sales

Operating profit

Ordinary profit

Profit attributable to owners of parent

Basic earnings per share

Six months ending May 31, 2026

Millions of

yen

%

Millions of

yen

%

Millions of

yen

%

Millions of

yen

%

Yen

18,200

4.6

3,100

6.1

3,200

5.2

2,200

3.2

107.50

Full year

37,500

3.4

6,400

3.4

6,600

0.6

4,500

(34.7)

220.00

Note: Revisions to the financial result forecast most recently announced: None

* Notes

(1) Significant changes in the scope of consolidation during the period:

Yes

Newly included:

1

company (

Visnex Chemicals Corporation

)

Excluded:

-

companies (

)

(2) Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements:

None

(3) Changes in accounting policies, changes in accounting estimates, and restatement

(i)

Changes in accounting policies due to revisions to accounting standards and other regulations:

None

(ii)

Changes in accounting policies due to other reasons:

None

(iii)

Changes in accounting estimates:

None

(iv)

Restatement:

None

(4) Number of issued shares (common shares)

(i) Total number of issued shares at the end of the period (including treasury shares)

As of February 28, 2026

22,410,038

shares

As of November 30, 2025

22,410,038

shares

(ii)

Number of treasury shares at the end of the period

As of February 28, 2026

2,072,767

shares

As of November 30, 2025

2,072,767

shares

(iii) Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)

Three months ended February 28, 2026

20,337,271

shares

Three months ended February 28, 2025

20,726,729

shares

* Review of the Japanese-language originals of the attached consolidated quarterly financial statements by certified public

accountants or an audit firm:

None

* Proper use of earnings forecasts, and other special matters

The forward-looking statements in this document, including forecasts of financial results, are based on information currently available to the Company and are subject to a number of uncertainties. Accordingly, actual results may differ from the forecasts due to changes in business conditions and other factors. Please refer to "Explanation of Consolidated Financial Results Forecast and Other Forward-looking Statements" on page 3 of the attached materials for matters related to forecasts of

financial results.

〇 Contents of Attachments

  1. Overview of Results of Operations 2

    1. Results of Operations for the Period under Review 2

    2. Financial Position for the Period under Review 3

    3. Explanation of Consolidated Financial Results Forecast and Other Forward-looking Statements 3

  2. Quarterly Consolidated Financial Statements and Primary Notes 4

    1. Quarterly Consolidated Balance Sheet 4

    2. Quarterly Consolidated Statements of Income and Comprehensive Income 6

    3. Notes to Quarterly Consolidated Financial Statements 8

Going Concern Assumption 8

Notes to Quarterly Consolidated Statements of Cash Flows 8

Changes in Scope of Consolidation or Scope of Application of Equity Method 8

Segment and Other Information 8

Significant Subsequent Events 9

  1. Overview of Results of Operations
    1. Results of Operations for the Period under Review

      During the three months ended February 28, 2026, the Japanese economy showed a moderate recovery trend against the backdrop of the improvement in the employment and income environment, with signs of a pickup in personal consumption and capital investment. On the other hand, the outlook remains uncertain due to the continued rise in prices, trends in raw material and energy prices, the increasing geopolitical risks stemming from the escalating situation in the Middle East, as well as foreign exchange fluctuations, overseas economic conditions, and developments in trade policies in various countries.

      Under these circumstances, we launched the new medium-term management plan Progress & Development 2030 (P&D 2030) covering the period from the fiscal year ended November 30, 2024 to the fiscal year ending November 30, 2030. Based on our Group management philosophy, P&D 2030 has set a management vision of "providing value to the global market as a leading company in specialty acrylic acid esters." Under this vision, we will promote sustainable management that takes ESG into account, aiming to increase corporate value and achieve sustainable growth.

      In the Chemical Products Business, we worked to improve profit ratios mainly by integrating and closing products and improving production efficiency, and proceeded with expanding sales of environmentally friendly products, such as those derived from biomass. In the Electronic Materials Business, the Group worked to accelerate the development of cutting-edge semiconductor materials and to develop new applications for photoresist materials. In the Specialty Chemicals Business, the Group focused on strengthening the overseas expansion of cosmetic raw materials and expanding sales of high-purity special solvents. Following OSAKA ORGANIC CHEMICAL INDUSTRY KOREA LTD. established in 2024, we established Visnex Chemicals Corporation in North America in 2025, and we are working to strengthen our overseas sales system by acquiring new customers and cultivating new markets. In addition, in anticipation of future growth in the semiconductor market, we are planning capital investment in new facilities for cutting-edge semiconductor materials at the Sakata Plant, and it is scheduled to be completed in 2028 in order to strengthen future production capacity and supply systems.

      As a result, for the three months ended February 28, 2026, the Group recorded net sales of 9,072 million yen (up 6.5% year on year), operating profit of 1,832 million yen (up 34.2% year on year), ordinary profit of 1,904 million yen (up 28.6% year on year), and profit attributable to owners of parent of 1,285 million yen (up 24.2% year on year).

      Business results by segment are explained below (excluding inter-segment transactions).

      1. Chemical Products Business

        In the Chemical Products Business, sales of automotive coatings, display adhesives, and UV inkjet inks all decreased in the acrylic acid ester group. Sales in the methacrylate ester group also remained weak. As a result, net sales were 2,807 million yen (down 15.4% year on year) and segment profit was 418 million yen (down 20.6% year on year).

      2. Electronic Materials Business

        In the Electronic Materials Business, in the semiconductor materials group, sales of raw materials for ArF resists, which are the Company's mainstay, remained strong, and sales of raw materials for cutting-edge EUV resists increased significantly. On the other hand, sales in the display materials group remained weak. In addition, sales of other groups remained strong. As a result, net sales were 4,552 million yen (up 22.2% year on year) and segment profit was 983 million yen (up 85.6% year on year).

      3. Specialty Chemicals Business

        In the Specialty Chemicals Business, sales in the cosmetics materials group were flat. Sales in the functional materials group increased significantly. In addition, sales of high-purity specialty solvents at subsidiaries remained strong. As a result, net sales were 1,713 million yen (up 16.1% year on year) and segment profit was 440 million yen (up 39.8% year on year).

    2. Financial Position for the Period under Review

      Total assets at the end of the first quarter of the current fiscal year increased by 1,738 million yen from the end of the previous fiscal year to 65,452 million yen. This was mainly attributable to a decrease of 704 million yen in cash and deposits and an increase of 2,570 million yen in investment securities due to the rise in stock prices, etc. of shares held. Liabilities at the end of the first quarter of the current fiscal year decreased by 640 million yen from the end of the previous fiscal year to 12,536 million yen. This was mainly due to an increase of 442 million yen in accounts payable

      - trade, a decrease of 369 million yen in accounts payable - other, a decrease of 1,587 million yen in income taxes payable, and an increase of 873 million yen in deferred tax liabilities.

      Net assets at the end of the first quarter of the current fiscal year increased by 2,379 million yen from the end of the previous fiscal year to 52,916 million yen. This was mainly due to an increase of 472 million yen in retained earnings and an increase of 1,745 million yen in valuation difference on available-for-sale securities.

    3. Explanation of Consolidated Financial Results Forecast and Other Forward-looking Statements

    The consolidated financial results forecast announced on January 8, 2026 remain unchanged.

  2. ‌Quarterly Consolidated Financial Statements and Primary Notes
  1. ‌Quarterly Consolidated Balance Sheet

    (Thousands of yen)

    As of November 30, 2025

    As of February 28, 2026

    Assets

    Current assets

    Cash and deposits

    15,922,597

    15,218,165

    Accounts receivable - trade, and contract assets

    11,579,782

    11,250,181

    Electronically recorded monetary claims -operating

    449,027

    464,238

    Finished goods

    4,711,762

    5,149,941

    Work in process

    2,119,445

    2,323,731

    Raw materials and supplies

    2,326,098

    2,520,492

    Other

    717,767

    726,084

    Allowance for doubtful accounts

    (20,403)

    (20,363)

    Total current assets

    37,806,078

    37,632,472

    Non-current assets

    Property, plant and equipment

    Buildings and structures, net

    7,846,424

    7,735,992

    Machinery, equipment and vehicles, net

    6,042,474

    5,785,603

    Land

    2,172,476

    2,172,476

    Construction in progress

    325,787

    310,929

    Other, net

    441,508

    458,398

    Total property, plant and equipment

    16,828,670

    16,463,399

    Intangible assets

    Goodwill

    3,333

    -

    Other

    35,837

    35,484

    Total intangible assets

    39,170

    35,484

    Investments and other assets

    Investment securities

    7,544,551

    10,114,984

    Shares of subsidiaries and associates

    298,567

    -

    Retirement benefit asset

    1,058,963

    1,068,763

    Deferred tax assets

    3,297

    3,391

    Other

    134,426

    133,940

    Total investments and other assets

    9,039,805

    11,321,079

    Total non-current assets

    25,907,647

    27,819,963

    Total assets

    63,713,725

    65,452,436

    (Thousands of yen)

    As of November 30, 2025

    As of February 28, 2026

    Liabilities

    Current liabilities

    Accounts payable - trade

    5,775,037

    6,217,130

    Current portion of long-term borrowings

    534,082

    509,132

    Accounts payable - other

    1,914,021

    1,544,515

    Income taxes payable

    2,117,602

    530,258

    Provision for bonuses

    -

    281,018

    Provision for bonuses for directors (and other

    officers)

    63,970

    9,713

    Other

    813,791

    711,974

    Total current liabilities

    11,218,505

    9,803,743

    Non-current liabilities

    Long-term borrowings

    803,841

    691,327

    Deferred tax liabilities

    1,014,083

    1,887,962

    Provision for share awards for directors (and other officers)

    26,780

    42,704

    Retirement benefit liability

    499

    507

    Other

    113,513

    110,004

    Total non-current liabilities

    1,958,717

    2,732,506

    Total liabilities

    13,177,222

    12,536,250

    Net assets

    Shareholders' equity

    Share capital

    3,600,295

    3,600,295

    Capital surplus

    3,513,349

    3,513,349

    Retained earnings

    44,177,940

    44,650,144

    Treasury shares

    (5,326,546)

    (5,326,546)

    Total shareholders' equity

    45,965,038

    46,437,242

    Accumulated other comprehensive income

    Valuation difference on available-for-sale

    securities

    3,140,180

    4,885,595

    Foreign currency translation adjustment

    186,810

    220,951

    Remeasurements of defined benefit plans

    408,689

    403,150

    Total accumulated other comprehensive income

    3,735,680

    5,509,697

    Non-controlling interests

    835,783

    969,246

    Total net assets

    50,536,502

    52,916,186

    Total liabilities and net assets

    63,713,725

    65,452,436

  2. ‌Quarterly Consolidated Statements of Income and Comprehensive Income

    ‌Quarterly Consolidated Statement of Income For the Three-Month Period‌

    (Thousands of yen)

    For the three months ended February 28, 2025

    For the three months ended February 28, 2026

    Net sales

    8,516,926

    9,072,876

    Cost of sales

    5,846,560

    5,947,511

    Gross profit

    2,670,366

    3,125,364

    Selling, general and administrative expenses

    1,304,495

    1,292,384

    Operating profit

    1,365,870

    1,832,979

    Non-operating income

    Interest income

    2,771

    1,747

    Dividend income

    36,842

    39,550

    Foreign exchange gains

    -

    6,215

    Insurance claim income

    97,183

    -

    Other

    28,683

    25,971

    Total non-operating income

    165,480

    73,484

    Non-operating expenses

    Interest expenses

    2,406

    1,153

    Foreign exchange losses

    45,193

    -

    Commission for purchase of treasury shares

    2,400

    -

    Loss on investments in investment partnerships

    506

    904

    Other

    0

    95

    Total non-operating expenses

    50,507

    2,153

    Ordinary profit

    1,480,843

    1,904,310

    Extraordinary losses

    Loss on retirement of non-current assets

    199

    2,926

    Total extraordinary losses

    199

    2,926

    Profit before income taxes

    1,480,644

    1,901,383

    Income taxes - current

    466,937

    510,839

    Income taxes - deferred

    (68,048)

    63,092

    Total income taxes

    398,888

    573,931

    Profit

    1,081,755

    1,327,451

    Profit attributable to non-controlling interests

    46,306

    41,757

    Profit attributable to owners of parent

    1,035,449

    1,285,694

    ‌Quarterly Consolidated Statement of Comprehensive Income For the Three-Month Period‌

    (Thousands of yen)

    For the three months ended February 28, 2025

    For the three months ended February 28, 2026

    Profit

    1,081,755

    1,327,451

    Other comprehensive income

    Valuation difference on available-for-sale securities

    (211,286)

    1,758,033

    Foreign currency translation adjustment

    (32,776)

    34,730

    Remeasurements of defined benefit plans, net of tax

    (2,559)

    (5,678)

    Total other comprehensive income

    (246,623)

    1,787,085

    Comprehensive income

    835,132

    3,114,537

    Comprehensive income attributable to

    Comprehensive income attributable to owners of

    parent

    788,214

    3,059,712

    Comprehensive income attributable to non-controlling interests

    46,917

    54,825

  3. Notes to Quarterly Consolidated Financial Statements Going Concern Assumption

    Not applicable.

    Notes to Quarterly Consolidated Statements of Cash Flows

    The quarterly consolidated statements of cash flows for the three months ended February 28, 2026 have not been prepared.

    Depreciation related to the three months ended February 28, 2026 (including amortization related to intangible assets excluding goodwill) and amortization of goodwill are as follows.

    (Thousands of yen)

    For the three months ended February 28, 2025

    (Dec. 1, 2024 - Feb. 28, 2025)

    For the three months ended February 28, 2026

    (Dec. 1, 2025 - Feb. 28, 2026)

    Depreciation

    721,502

    657,589

    Amortization of goodwill

    4,999

    3,333

    Changes in Scope of Consolidation or Scope of Application of Equity Method

    (Significant Change in the Scope of Consolidation)

    Visnex Chemicals Corporation, which was a non-consolidated subsidiary in the previous fiscal year, is included in the scope of consolidation from the first quarter of the current fiscal year due to its increased importance.

    Segment and Other Information

    [Segment Information]

    1. For the three months ended February 28, 2025 (Dec. 1, 2024 - Feb. 28, 2025)

      1. Information on the amounts of sales, profits or losses by reportable segment and information on disaggregation of revenue

        (Thousands of yen)

        Reportable segment

        Adjustment (Note 1)

        Amounts shown on quarterly consolidated statement of income

        (Note 2)

        Chemical Products Business

        Electronic Materials Business

        Specialty Chemicals Business

        Total

        Net sales

        Japan

        1,586,393

        3,154,050

        1,113,708

        5,854,152

        -

        5,854,152

        Asia and Australia

        1,215,493

        563,431

        307,617

        2,086,542

        -

        2,086,542

        Americas

        359,255

        6,614

        54,785

        420,654

        -

        420,654

        Europe

        155,006

        570

        -

        155,576

        -

        155,576

        Revenue from contracts with

        customers

        3,316,149

        3,724,665

        1,476,110

        8,516,926

        -

        8,516,926

        Other revenues

        -

        -

        -

        -

        -

        -

        Sales to external customers

        3,316,149

        3,724,665

        1,476,110

        8,516,926

        -

        8,516,926

        Inter-segment sales and

        transfers

        -

        -

        118,196

        118,196

        (118,196)

        -

        Total

        3,316,149

        3,724,665

        1,594,307

        8,635,123

        (118,196)

        8,516,926

        Segment profit

        527,628

        530,126

        315,210

        1,372,965

        (7,094)

        1,365,870

        (Notes) 1. Segment profit in the above adjustment represents eliminations for inter-segment transactions.

      2. Segment profit is adjusted to be consistent with the operating profit on the quarterly consolidated statement of income.

        2. Information related to impairment losses on non-current assets or goodwill, etc. for each reportable segment Not applicable.

    2. For the three months ended February 28, 2026 (Dec. 1, 2025 - Feb. 28, 2026)

      1. Information on the amounts of sales, profits or losses by reportable segment and information on disaggregation of revenue

        (Thousands of yen)

        Reportable segment

        Adjustment (Note 1)

        Amounts shown on quarterly consolidated statement of income

        (Note 2)

        Chemical Products Business

        Electronic Materials Business

        Specialty Chemicals Business

        Total

        Net sales

        Japan

        1,476,316

        3,930,482

        1,361,695

        6,768,494

        -

        6,768,494

        Asia and Australia

        1,148,941

        619,314

        313,567

        2,081,822

        -

        2,081,822

        Americas

        62,177

        2,878

        22,951

        88,006

        -

        88,006

        Europe

        119,599

        -

        14,952

        134,551

        -

        134,551

        Revenue from contracts with

        customers

        2,807,034

        4,552,674

        1,713,166

        9,072,876

        -

        9,072,876

        Other revenues

        -

        -

        -

        -

        -

        -

        Sales to external customers

        2,807,034

        4,552,674

        1,713,166

        9,072,876

        -

        9,072,876

        Inter-segment sales and

        transfers

        -

        -

        147,573

        147,573

        (147,573)

        -

        Total

        2,807,034

        4,552,674

        1,860,739

        9,220,449

        (147,573)

        9,072,876

        Segment profit

        418,702

        983,952

        440,817

        1,843,472

        (10,492)

        1,832,979

        (Notes) 1. Segment profit in the above adjustment represents eliminations for inter-segment transactions.

      2. Segment profit is adjusted to be consistent with the operating profit on the quarterly consolidated statement of income.

2. Information related to impairment losses on non-current assets or goodwill, etc. for each reportable segment Not applicable.

Significant Subsequent Events

Not applicable.

Company analysis

Earlier from Osaka Organic Chemical Industry

All Osaka Organic Chemical Industry news releases